Drug intelligence / Profile preview

2',5'-dideoxy-adenosine 3'-monophosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:**\n2',5'-Dideoxy-Adenosine 3'-Monophosphate is a synthetic nucleoside monophosphate analog of adenosine. It belongs to the class of ribonucleoside phosphates and is characterized by the absence of hydroxyl groups at the ribose positions C'₂ and C'₅. This compound has been primarily used as an experimental tool in biochemical research rather than as a therapeutic agent. Its main mechanism involves acting as an inhibitor of adenylyl cyclase (also known as adenylate cyclase), thereby reducing cellular cyclic AMP (cAMP) levels. By mimicking natural nucleotides but lacking key functional groups required for enzymatic activity or further phosphorylation/elongation in nucleic acids or signaling pathways, it serves to block cAMP-mediated signal transduction[1][7]. There are no approved clinical indications for this molecule; it is classified as an experimental small molecule[1][3].

Other names
2',5'-DIDEOXYADENOSINE 3'-MONOPHOSPHATE2',5'-dideoxyadenosine 3’-monophosphate(((2R,3S,5R)-5-(6-amino-9H-purin-9‑yl)-2-methyloxolan‑3‑yl)oxy)phosphonic acid{[(2R,3S,5R)-5-(6-amino‑9H-purin‑9‑yl)-2-methyloxolan‑3‑yl]oxy}phosphonic acid[(2R,3S,5R)-5-(6-amino­purin–9–yl)–2-methyloxolan–3–yl] dihydrogen phosphate121878‐11‐32’,5’-dideoxyadenosine 3’-phosphoric acid[(2R,3S,5R)-5-(6-amino­purin–9–yl)–2-methyloxolan–3–yl] oxyphosphonic acid
02

Targets

AC (Adenylyl cyclase family)

Beyond the preview

Go deeper on 2',5'-dideoxy-adenosine 3'-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2',5'-dideoxy-adenosine 3'-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call